| 1. | The study found the increased risk most acute for cancer involving so - called estrogen - receptor positive tumors 研究发现,西式饮食对雌激素受体阳性肿瘤作用最明显。 |
| 2. | It could become the basis for deciding how patients with estrogen - receptor - positie breast cancer are treated clinically 以前的研究表明,雌激素促进大多数乳癌的生长。 |
| 3. | It could become the basis for deciding how patients with estrogen - receptor - positive breast cancer are treated clinically 它可决定雌激素受体阳性的乳癌患者如何临床治疗。 |
| 4. | Study limitations included the lack of recording for tumor grade and estrogen - receptor status , and the possibility of misclassification of some hereditary cases 本研究的局限性包括缺乏肿瘤分级和雌激素受体状态的记录,以及可能对某些遗传性病例分类错误。 |
| 5. | Conclusions the recurrence score has been vakidated as quantifying the kikekihood of distant recurrence in tamoxifen - treated patients with node - negative ? estrogen - receptor - positive breast cancer 结论研究证实复发评分可量化淋巴结阴性、雌激素受体阳性、接受他莫昔芬治疗的乳腺癌患者的远处复发可能性。 |
| 6. | According to the national cancer institute , about two - thirds of women with breast cancer have estrogen - receptor - positive breast cancer , in which tumor growth is regulated by the natural female hormone estrogen 根据国家癌症研究所的资料,大约2 / 3的女性乳癌患者雌激素受体阳性,肿瘤的生长受天然的雌激素调控。 |
| 7. | Since evidence shows anti - estrogen drugs will fail in a many patients with estrogen - receptor - positive breast cancer , says knudsen , our research suggests that physicians should examine both estrogen receptor status and rb tumor suppressor status during the initial diagnosis , in order to prescribe the most effective therapy for that specific patient ' s cancer . 证据表明,抗雌激素药物对雌激素受体阳性乳癌将失效,我们的研究提示,为了给那些特殊癌症患者制定最有效的治疗方法,医生应该在开始诊断时检测雌激素受体和rb抑癌基因状况。 |
| 8. | Since eidence shows anti - estrogen drugs will fail in a many patients with estrogen - receptor - positie breast cancer , says knudsen , our research suggests that physicians should examine both estrogen receptor status and rb tumor suppressor status during the initial diagnosis , in order to prescribe the most effectie therapy for that specific patient ' s cancer . 证据表明,抗雌激素* *物对雌激素受体阳性乳癌将失效,我们的研究提示,为了给那些特殊癌症患者制定最有效的治疗方法,医生应该在开始诊断时检测雌激素受体和rb抑癌基因状况。 |